ABNORMAL LIGHT-CHAIN TESTING AND DIAGNOSIS OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) AMONG PATIENTS REFERRED FOR TECHNETIUM-99M PYROPHOSPHATE IMAGING
Matthew Cozzolino(Boston University), Frederick L. Ruberg(Boston University), John L. Berk(Boston University), Deepa M. Gopal(Boston University), Brian Lilleness(Boston University), Vaishali Sanchorawala(Boston Medical Center), Eric T. Guardino(Boston University), Omar K. Siddiqi(Boston University), Rabah Alreshq(Boston University), Alexandra Pipilas(Boston University), Varsha Muralidhar(Boston University)
Cited by 0
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
|Science|2017|1.5k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k